Wuhan Jianmin Pharmaceutical Group
Wuhan Jianmin Pharmaceutical engages in the research and development, production, and sale of pharmaceuticals primarily in China.
Launch date
Employees
Market cap
$857m
Enterprise valuation
$771m (Public information from Sep 2024)
Share price
CNY41.65 600976.SS
Wuhan Hubei (HQ)
Authorizing premium user...